Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 3Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 8Genitourinary 6Breast 6Thoracic 5Gynecologic 5Gastrointestinal 5Tumor-Agnostic 4Plasma cell 4Other hematologic neoplasm 4Sarcoma 2Head & Neck 2Other solid neoplasm 1Myeloid 1

Conditions

Neoplasms 4

Interventions

pembrolizumab 95Paclitaxel 86Gemcitabine 84Carboplatin 79Surveys and Questionnaires 72Docetaxel 61Bevacizumab 61Nivolumab 59Cisplatin 59Magnetic Resonance Spectroscopy 50Blood Specimen Collection 50Fluorouracil 48Radiotherapy 47Capecitabine 47Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 38Biopsy 36atezolizumab 35Leucovorin 35Pemetrexed 34Standard of Care 32Cetuximab 32Specimen Handling 31Trastuzumab 30Radiosurgery 29Ipilimumab 28Cyclophosphamide 28Interviews as Topic 27olaparib 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Geriatric Assessment × Tumor-Agnostic × Clear all
NCT02000011 2022-11-14

epigac

Assistance Publique Hopitaux De Marseille

Phase NA Completed
50 enrolled
Tumor-Agnostic

Neoplasms

NCT03881137 2022-11-09

Improved Function and Quality of Life for Older Patients Receiving Radiotherapy, Part II

Sykehuset Innlandet HF

Phase NA Completed
178 enrolled
Tumor-Agnostic

Neoplasms

NCT03154671 2022-05-20

Comprehensive Geriatric Assessment and Management for Canadian Elders With Cancer

University of Toronto

Phase NA Completed
351 enrolled
Tumor-Agnostic

Neoplasms

NCT02671994 2019-01-04

GOAT

Odense University Hospital

Phase NA Unknown
114 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡